StockData
Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc. (SGMT) stock

SGMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$9.85−0.28 (-2.76%)

Close on Nov 17, 2026Market cap $612.26MP/E –Yield –

Sagimet Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Sagimet Biosciences's market cap was $429.77M on Nov 11, 2026, against $233.12M a year earlier. Over the last 2 years it ranged from $769.75K to $429.77M, with a median of $230.62M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$429.77M+124.8%
2025Dec 31, 2025$191.14M+24731.5%
2023Oct 31, 2023$769.75K–

More Sagimet Biosciences figures

See a number that looks wrong?